Patients with the genetic disorder ataxia telangiectasia (AT) have mutations in the AT mutated (ATM) gene, which is homologous to TEL1 and the checkpoint gene MEC1. A tell deletion mutant, unlike a mecl deletion, is viable and does not exhibit increased sensitivity to DNA-damaging agents. However, increased dosage of TEL1 rescues sensitivity of a mecl mutant, mecl-1, to DNA-damaging agents and rescues viability of a mecl disruption, mecl.1 tellA1 double mutants are synergistically sensitive to DNA-damaging agents, including radiomimetic drugs. These data indicate that TEL 1 and MEC1 are functionally related and that functions of the ATM gene are apparently divided between at least two S. cerevisiae homologs.
Introduction
Ataxia telangiectasia (AT) is an autosomal recessive disorder characterized by progressive cerebellar ataxia, dilated blood vessels in the eyes and skin (oculocutaneous telangiectasias), cellular and humoral immune deficiencies, hypersensitivity to ionizing radiation, and increased predisposition for leukemias and lymphomas (reviewed by Friedberg et al., 1995; Shiloh, 1995) . The incidence of AT is estimated at one in 40,000 to one in 100,000 live births. These homozygous patients are approximately 100 times more likely to develop cancer than the general population . AT heterozygous carriers, who represent approximately 1% of the population , reportedly have a 3-to 4-fold increase in cancer predisposition (Swift et al., 1991) .
Cell lines derived from AT patients exhibit higher levels of chromosome breakage, rearrangement, and loss, a reduced life span in culture, higher requirements for serum growth factors, and defects in the cytoskeletal actin fibers (reviewed by Shiloh, 1995) . AT cells also demonstrate increased sensitivity to ionizing radiation (Taylor et al., 1975) and radiomimetic chemicals (McKinnon, 1987) , as well as resistance to inhibition of DNA synthesis (radioresistant DNA synthesis) after ionizing radiation (Painter, 1985) . This evidence suggests that AT cells might be deficient in their ability to arrest or delay the cell cycle following DNA damage (Painter et al., 1982; Kastan et al., 1992) .
Amino acid sequence comparison of the product of the recently cloned gene mutated in AT (ATM) (Savitsky et al., 1995) shows significant homology of the carboxyl terminus to lipid kinases, particularly phosphatidylinositol 3-kinases (PI3Ks). In mammalian cells, PI3Ks are involved in gener.. ating early signals required for mitogenesis, as well as regulating the actin cytoskeleton (reviewed by Fry, 1994) , in which AT patients have known defects. In the budding yeast, Saccharomyces cerevisiae, several genes have been identified with putative lipid kinase domains, including MEC1/ESR1 (Weinert et al., 1994; Kato and Ogawa, 1994) , TOR 1/DRR1 and TOR2/DRR2 (Heitman et al., 1991 ; Cafferkey et al., 1993; Kunz et al., 1993; Brown et al., 1994) , and VPS34 (Herman and Emr, 1990; Schu et al., 1993) , as well as an uncharacterized open reading frame (ORF), YBL088 (Feldmann et al., 1994) . Since a deletion of VPS34 eliminates all detectable PI3K activity, it is likely that the other lipid kinase-containing proteins phosphorylate inositol in a different position (Schu et al., 1993) or possibly even lack lipid kinase activity. The other S. cerevisiae homologs, MEC1/ESR1, TOR1/DRR1, and TOR2! DRR2, all appear to function in cell cycle regulation. MEC1/ ESR1, an essential gene, was originally identified by Weinert et al. (1994) in a genetic screen for mutants (mecl-1) that exhibit a rapid death phenotype after shifting to nonpermissive temperatures in a cdc13 mutant background. MEC1/ESR1 was independently cloned by Kato and Ogawa (1994) in a screen for mutants that are sensitive to methyl methanesulfonate and defective in meiotic recombination. It is apparent, therefore, that MEC1 is not only required for cell cycle delay or arrest at both S and G2 in response to DNA damage, and for proper meiosis, but has other essential, currently unknown functions (Weinert et al., 1994; Kato and Ogawa, 1994) . The homologs TOR1/DRR1 and TOR2/DRR2, identified in screens for rapamycinresistant yeast strains, have also been shown to be required for G1 progression (Kunz et al., 1993; Brown et al., 1994) . tor2 mutants appear to arrest randomly in the cell cycle, but torl tor2 double mutants arrest in G1 (Kunz et al., 1993) . It was suggested that TOR1 and TOR2 might be components of a signal transduction pathway that interact with G 1 cyclins, similar to the interleukin-2 signal transduction pathway of T cells.
Our primary purpose in initiating these studies was to use yeast as a model system for studying the cellular phenotypes found in AT patients. In particular, we focused on the unknown ORF (YBL088) because it was more homologous to ATM than any of the other lipid kinases currently in the sequence data bases. (After completion of the work presented here, we learned that YBL088 is equivalent to TEL1 [Greenwell et al., 1995 [Lustig and Petes, 1986] .) TEL1 and MEC1 also contain a region of homology to the Schizosaccharomyces pombe gene rad3, which is required for G2 arrest after DNA damage (Seaton et al., 1992) . It is this rad3 homology that distinguishes ATM, TEL1, and MEC1 from the other lipid kinase genes. The finding that tell-1 has telomere defects is particularly intriguing in light of the potential telomere defects identified in AT patient cell lines (Pandita et al., 1995) . In this study, we demonstrate that TEL1 is functionally related to MECI. Our finding is based on TEL1 rescue of mecl-1 sensitivity to DNA-damaging agents. In addition, we show that TEL1 can substitute for the essential function(s) provided by MEC1 and that mecl-1 tellA 1 double mutants are synergistically sensitive to ionizing radiation, ultraviolet light (UV), hydroxyurea (HU), and radiomimetic drugs. We suggest that TEL1 and MEC1 function in redundant checkpoint pathways and that functional analysis of the phenotypes of AT cells may be aided by studying the S. cerevisiae ATM homologs, TEL1 and MEC1.
Results
Human ATM Is Most Homologous to S. cerevisiae TEL1 Basic local alignment search technique protein (BLASTP; Altschul et al., 1990 ) computer analysis of the complete 3056 amino acid ATM sequence (K. Savitsky, personal communication) demonstrates that TEL1 is significantly more homologous to ATM than any other gene currently sequenced (BLASTP score of 10 -91 for Tellp compared with 10 -~9 for Meclp). The original BLASTP analysis of a partial A TM clone 7-9 (Savitsky et al., 1995) also showed greatest homology to TEL1, previously annotated as an uncharacterized ORF(YBL088). In addition, of the 14ATM patient mutations sequenced, seven were frameshift truncations (three are shown in Figure 1A ), one was a deletion, and six (representing four families) were small in-frame deletions ( Figure 1B ; Savitsky et al., 1995) . These six inframe deletions fell into one of three categories diagrammed in Figure lB . Three-way alignments of the corresponding amino acid sequences from these patients shows that in two of the three cases a residue conserved between ATM and Tellp, but not between ATM and Meclp, is deleted ( Figure 1B) . We conclude from this and the BLASTP scores that ATM is more similar to TEL1 than to MEC1.
Deletion of TEL1 Does Not Increase Sensitivity to DNA-Damaging Agents
A complete and precise deletion of the TEL10RF was generated using the deletion technique of Baudin et al. (1993) (Figure 2A; is not an essential gene and that deletion of TEL1 has no obvious effect on growth. One of the major clinical features of AT is sensitivity to a variety of DNA-damaging agents, including ionizing radiation and radiomimetic drugs. The haploid tellA1 strain (YDM884)as well as homozygous (YDM890, tellA 1/ tell A 1) and heterozygous (YDM881, tell A 1~-I-EL1) diploid strains were tested for sensitivity to ionizing radiation, several radiomimetic drugs (bleomycin and streptonigrin), and the drug ethyl methanesulfonate. No significant difference in viability was observed between wild-type and tell mutant strains after exposure to ionizing radiation ( Figure  3 ) or after radiomimetic drug treatment (data not shown), although a 2-to 3-fold reduction in viability of tellA 1 was observed at high concentrations (4.5%) of ethyl methanesulfonate (data not shown). These data suggest that a complete deletion of TEL1 does not mimic these particular AT phenotypes. The tellA 1 null mutant was also tested for sensitivity to both UV and HU, since MEC1/ESR1 mutants 
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Figure 2. Schematic of tell Deletion Strains and Gap Repair of the TEL1 Gene (A) PCR primer sequence was determined (see Table 3 for primer sequence) based on corresponding regions of homology between A TM and TEL1 (see also Figure 1A ). Primers contained a region of homology to pRS (indicated by arrows). Primers 5, 6, and 7 contain the TAA termination codon (asterisks). pRS303 (HIS3) vector was amplified with the indicated primers and transformed into YPH274. The resulting tell truncation mutants are listed and schematically diagrammed. (B) YDM881 (telIAI::HIS3/TEL1 heterozygous strain) genomic DNA was amplified using primers 1 and 4 flanking the wild-type TEL1 gene. The resulting 3.2 kb PCR product was gel purified, digested with EcoRI and Spel, and subcloned into pRS316. The resulting gap repair plasmid was linearized with the EcoR47111 unique to the HIS3 gene and transformed into wild-type (YPH274) yeast. Ura ÷ transformants were replica plated onto synthetic media lacking histidine, and Ura-His transformants were selected for further analysis. Genomic DNA from Ura + His strains was isolated and transformed into bacteria. Bacteria containing successfully gap-repaired plasmid grew slowly.
(mecl-1 and esrl-1, respectively), but not AT cells, exhibit sensitivity to these treatments. No significant difference in viability compared with wild type was observed (data not shown).
One of the most intriguing features of the mutations found to date in AT patients is the preponderance of frameshift mutations that result in premature termination of the protein (Savitsky et al., 1995; K. Savitsky, personal communication). We therefore tested truncation mutations of MEC1 and TEL1 for potential dominant interfering
Gamma Irradiation Dose (krads) Figure 3 . tell Deletion StrainsAre Not Sensitive to Ionizing Radiation Wild-type diploid (YPH274) or haploid (YDM885) strains, heterozygous (YDM881) or homozygous (YDM890) diploid tell deletion strains, tellA 15LA truncation mutant (YDM950) strain, or mecl-1 (TWY308) mutant strain were grown to middle-log phase and exposed to ionizing radiation at the doses indicated. Equal numbers of cells were plated, and cell viability was determined 2 days later. Standard deviations are shown using two to fou r samples. The experiment was performed three times with similar results.
effects with normal checkpoint function (see Figures 1A and 2A). All three truncation mutants of tell were viable, and no increase in sensitivity to ionizing radiation (see telIA15LA in Figure 3) , UV, or HU was observed (data not shown), whereas all three truncation mutants of mecl were inviable. These data suggest that tru ncation mutants of TEL1 do not exhibit a dominant interfering phenotype.
Cloning the TEL1 Gene Despite observing no apparent sensitivity to ionizing radiation in tell mutants, we hypothesized that since Tellp and Meclp are homologous (48% similar and 22% identical), they might be functionally related or partially redundant proteins. To test this hypothesis it was necessary to clone the TEL 1 gene. We first attempted to clone TEL 1 by screening a LEU2/CEN genomic library, but were unable to obtain any full-length clones (see Experimental Procedures). It appeared that several DNA inserts had undergone rearrangements, perhaps because the TELl-containing plasraids were toxic to the bacteria. To clone the gene successfully, we devised a gap repair strategy (see Figure 2B) Bacteria transformed with successfully gap-repaired plasmid grew slowly, supporting the possibility that TEL1 is toxic in bacteria. Subsequent comparison of restriction patterns with that predicted by the genomic sequence indicated that the complete TEL 1 gene plus flanking sequence was present (termed pDM197).
TEL1 Is Functionally Related to MECl
To test our hypothesis that TEL1 and MEC1 might be functionally related, we used cross-complementation studies with the mecl-1 mutant. The mecl-1 strain was transformed with either vector alone (pRS316) or the TEL 1-co ntaining URA3/CEN plasmid (pDM197). Figure 4A shows that 32 kR of ionizing radiation killed most mecl-1 cells containing the plasmid control. However, mecl-1 transformed with pDM197 showed healthy colony growth after irradiation ( Figure 4B ). The percentage of viable cells after irradiation is similar to that observed with wild type ( Figure  4E ), although complete rescue of viability was not obtained. This suggests that increased expression of TEL1 at CEN copy levels cannot fully compensate for m e c l -l . Similar results were also seen when cells were exposed to UV ( Figure 4F ). Increasing doses of UV cause rapid death of mecl-1 containing the plasmid control, but CENlevel expression of TEL1 was capable of rescuing viability to near wild-type levels. At 60 Jim 2, for example, only 0.1% of mecl-1 cells are viable; however, with the TELl-containing plasmid approximately 15%-20% of the cells survive. This is similar to the 30%-40% survival for wild-type strains. Even at higher UV doses, the viability was close to wild type. The ability of the TELl-containing plasmid to rescue the mecl-1 mutant sensitivity to H U was also tested. Wild-type cells are normally able to delay in S phase in the presence of HU, but the mecl-1 mutant does not and is thus extremely sensitive to HU treatment (Weinert et al., 1994; Kato and Ogawa, 1994) . It is presumed that inviability of mecl-1 in the presence of HU results from cells entering mitosis without fully replicated DNA. mecl-1 cells treated for 4 hr in 0.1 M HU show a log phase-type distribution of small budded and large budded cells, as well as high inviability, whereas wild-type cells virtually all delay with a large bud, and most cells remain viable. This is consistent with MEC1 being directly involved in an S phasespecific checkpoint (Weinert et al., 1994; Kato and Ogawa, 1994) . Figu re 4D shows that mec 1-1 cells transformed with pDM197 exhibit healthy colony growth 24 hr after exposure to HU treatment. Viability is similar to that seen in wild-type cells after such treatment (data not shown).
A plasmid control, pRS316 (A and C), or a TELl-containing URA/CEN plasmid, pDM197 (B and D), was transformed into the mecl-1 (TWY308) strain. The resulting strains were exposed to 32 kR of ionizing radiation (A and B) or 0.1 M HU for 4 hr (C and D). Photographs of colonies were taken 24 hr later. To determine the efficiency of pDM197 rescue, we determined viability after exposure to increasing dosage of ionizing radiation (E) or UV (F). Standard deviations are shown using two to four samples. Experiments were performed two times with similar results.
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TEL1 Rescues the Essential Function of MECl
MEC1 is required not only for both S phase and G2 checkpoint functions, but is also essential for viability, suggesting functions other than checkpoint maintenance (Weinert et al., 1994; Kato and Ogawa, 1994 These spores were all His + Ura ÷, and subsequent loss of the plasmid, as assayed by plating the cells on 5-fluoroerotic acid (Boeke et al., 1984) , caused death (data not shown). This suggests that an extra copy of TEL1 can provide the essential functions normally provided by M E C I .
Synergistic Interaction between tellA1 and mecl.1
Although the data provided thus far demonstrate that an extra copy of TEL1 can rescue both the m e c l -I sensitivity to DNA-damaging agents and inviability of the m e c l truncation mutant, there is no direct evidence that TEL1 is required for checkpoint function. We hypothesized that if TEL1 plays a role in checkpoint control, a te/1A 1 m e c l -1 double mutant might be more sensitive to DNA-damaging agents. Double mutant strains were generated by a genetic cross between m e c l -1 (TWY308) and te/1A 1 (YDM884). Four independent mecl-1 te/1A 1 double mutants (YDM935, YDM936, YDM937, and YDM938) were selected for further study. All four double mutant strains grew less well than wild-type strains and grew extremely poorly at 37°C (data not shown). When the double mutants were tested for sensitivity to ionizing radiation ( Figure 5A ), all four double mutants died at very low doses. When approximately 1500 cells were plated for each of the four double mutants, not a single cell survived a low dose (10 kR) of radiation and only 2 % -4 % survived after 5 kR of radiation:; examples (YDM936 and YDM937) are shown in Figure 5A . This contrasts with a dose of 32 kR required for essentially 100% killing of the m e c l -1 mutant and 200 kR for a wild-type or tellA 1 mecl-1 double mutant (YDM936 and YDM937) strains were exposed to increasing doses of ionizing radiation. Colony-forming units were determined 2-3 days later, and viability was determined by comparing irradiated plates with unirradiated control plates. Figure 5B . Of approximately 5000 cells plated for each of the four double mutants, not a single cell survived. This contrasts with a survival rate of about 1% for the mecl-1 mutant (TWY308) and 50%-60% for wild type (YDM911). The tellA 1 strain had viability levels equivalent to those of wild-type cells (data not shown). The double mutants were also more sensitive to UV treatment than wild type or either tellAl MEC1 or TEL1 mecl-1 single mutants (data not shown). These data indicate a genetic interaction between TEL1 and MEC1.
Double Mutants, but Not Single Mutants, Are Sensitive to Radiomimetic Drugs
It has been well documented that AT cells are sensitive to radiomimetic drugs, such as the peptides bleomycin (Lehmann and Stevens, 1979; Taylor et al., 1979) and the quinone-containing anti-tumor drug streptonigrin (Taylor et al., 1983) . These agents act presumably by introducing a specific type of strand scission via a free radical attack on the deoxydbose moiety (Shiloh et al., 1983) . To test the effects of radiomimetic drugs, we first determined a survival curve for wild-type yeast strains using a range of streptonigrin (5 ng/ml to 50 #g/ml) or bleomycin sulfate (10 ng/ml to 100 ~g/ml). Neither wild type nor either single mutant (tellA 1 or mecl-1) showed any difference in growth rate or viability at the highest concentrations tested (streptonigrin, 50 i~g/ml; bleomycin, 100 i~g/ml; data not shown). However, the tellA 1 mecl-1 double mutant died at 0.5 #,g/ ml of streptonigrin ( Figure 5C ) and 10 #g/ml of bleomycin ( Figure 5D ). The single mecl-1 TEL1 mutant is shown for comparison (0.5 ~,g/ml streptonigrin; Figure 5E ). Some residual growth of the double mutants in both streptonigrin and bleomycin was seen before the cells died. However, when these double mutants were subsequently restreaked onto yeast extract-peptone-dextrose (YPD) plates, the cells were inviable, suggesting that irreversible damage to the cells had occurred. These data indicate that a common phenotype of AT cells, sensitivity to radiomimetic drugs, occurs only in S. cerevisiae tellA 1 mecl-1 double mutant cells.
Discussion
We have undertaken a study of the TEL1 gene, which is highly homologous to the ATM gene found mutated in patients with AT (Savitsky et al., 1995 One possible explanation of the interaction between TEL1 and MEC1 is that they are redundantly involved in the same checkpoint pathways, but that TEL1 provides only modest checkpoint function compared with MEC1. Alternatively, it is possible that TEL1 and MEC1 function in different but overlapping checkpoint pathways and that increased dosage of either protein can compensate for loss of function of the other. Perhaps, for example, the type of DNA lesion that induces the MEC1 checkpoint pathways differs from the lesion that induces the TEL1 checkpoint pathways; MEC1 could be involved primarily in damage induced by agents such as ionizing radiation or HU, whereas TEL1 might function to recognize other types of DNA damage (e.g., shorter or damaged telomeres).
Which of these two S. cerevisiae genes is likely to be the true homolog of A TM (see Table 1 )? Based on a BLASTP similarity search, TEL 1 appears to be the more likely can di- increases (3-to 4-fold) were observed for chromosome loss and recombination.
date. Furthermore, when comparing the amino acid sequence of ATM with that of Tellp or Mecl p, it is apparent that disease-causing in-frame deletions in AT patients (Savitsky et al., 1995) are more conserved between A TM and TEL1 than with MEC1 (see Figure 1B) . However, mecl-1 mutants display phenotypes consistent with being the functional homolog of ATM, including sensitivity to ionizing radiation and defects in cell cycle arrest in response to DNA damage, mecl-1 mutants, however, also display additional phenotypes not characteristic of AT cells. For example, MEC1 is essential for viability, and mecl-1 mutants are sensitive to both UV and HU. TEL1 mutants, on the other hand, that do not display these phenotypes display other phenotypes of AT cells (Pandita et al., 1995) that mecl-1 mutants do not; in particular, it has been noted that tell mutants exhibit altered telomere metabolism, including shortening of telomeres (Greenwell et al., 1995) . This latter observation could explain the reduced life span and premature senescence seen in cell lines derived from AT patients. It is also well established that tumors have changes in both telomerase activity and in telomere length relative to their normal cellular counterparts that could account for genomic instability (Kim et al., 1994; Murnane et al., 1994) . In addition, TEL1 mutants also exhibit phenotypes common to AT cells, such as chromosome loss (Greenwell et al., 1995) , whereas sensitivity to radiomimetic drugs (at the doses tested) occurs only in tell/ll mecl-1 double mutant strains. Finally, AT patients exhibit high rates of translocations, particularly within the T cell receptor and immunoglobulin heavy chain genes (reviewed by Shiloh, 1995) and have been reported to have high rates of intrachromosomal recombination (Meyn, 1993) . Interestingly, mutations in either TEL1 (Greenwell et al., 1995) or MEC1/ESR1 (Kato and Ogawa, 1994 ) result in increased mitotic recombination. Thus, it appears that S. cerevisiae may not have a single functional homolog of ATM, but rather at least two nonallelic genes, TEL1 and MEC1, which might carry out separate but significantly overlapping functions. This is not an unprecedented situation. The NF1 gene responsible for the human genetic disorder neurofibromatosis type 1 (Wallace et al., 1990) , for example, which plays an important role in catalyzing the conversion of rasGTP (the active form) to rasGDP (the inactive form), appears to have two related and partially redundant homologs in S. cerevisiae, IRA 1 and IRA2 (Tanaka et al., 1990; Ballester et al., 1990) . In addition, Shani et al. (1995) have described two yeast genes (PXA1 and YXL741) that are homologous and functionally similar to X-linked adrenoleukodystrophy in humans (Shani et al., 1995) . In this case, mutations in either yeast gene cause phenotypes analogous to the human disease phenotype, suggesting the possibility of heteromeric interaction of protein subunits.
The genetic analysis of TEL1 function presented here underscores the utility in identifying relationships between human genes and genes from other organisms to help us better understand the molecular basis of human disease. It is well established that human mutations leading to genome instability can predispose an individual to cancer. Yeast, in particular, provides a powerful experimental system for a thorough analysis of genes required for genomic stability, including those that function in control of cell cycle progression. The recent identification of' MSH2 and MLH1, the genes mutated in hereditary nonpolyposis colon cancer (Leach et al., 1993; Papadopoulos et al., 1994; Bronner et al., 1994; Reenan and Kolodner, 1992; Fishel et al., 1993; Prolla et al., 1994) , via a cross-species candidate gene approach, and the subsequent cross-referencing of information gained in microbial systems about DNA mismatch repair to a basic understanding of colon cancer predisposition, demonstrates the value of yeast genetic studies to a basic understanding of cancer. Future genetic studies in yeast on TEL1 and MEC1 (as well as potential homologs yet to be discovered) may ultimately provide a basic understanding of cancer predisposition in AT patients and heterozygous carriers.
Experimental Procedures Yeast Strains and Yeast Transformation
Yeast strains used in this study are listed in Table 2 . Media and growth of yeast strains were as previously described (Rose et al., 1990) . All yeast cultures were grown at 30°C. Transformation of yeast with DNA was performed by the lithium acetate procedure as previously described (Ito et al., 1983) . For sensitivity studies, cells were grown overnight in YPD or minimal media and then reinoculated at OD600 = 0.1 and grown to early-to middle-log phase (OD~ = 0.3-0.4) before use. For Figure 3 , equal amounts of OD~ cells were irradiated in 3 ml of YPD at the doses indicated. Cell counts were taken, and 300 cells per plate were spread onto YPD plates. The number of ,cells surviving was determined 2-3 days later. For Figures 4 and 5, cells were grown as described above; cells were diluted to OD600 = 1.0, and dilution series were generated. We spotted 5 i11 of cells from each dilution onto YPD, or minimal media plates when selection for a plasmid was necessary, and irradiated the plates at the doses indicated. The number of colony-forming units was determined 1 day later, and viability was calculated by comparison with unirradiated controls.
Ionizing Radiation and UV Sensitivity Experiments
Ionizing radiation experiments were performed with a Shepard Mark I ~37Cs irradiator at a strength of 0.675 kR per minute. UV experiments were performed with a Stratagene UV Stratalinker 2400. For HU (Sigma) experiments, cells were grown as described above, diluted back to OD600 = 0.2, and grown for an additional 4 hr at 30°C in the presence of 0.1 M HU. Cell counts were taken, and equal numbers of cells were plated onto YPD or minimal media plates. Colony-forming units were determined 2-3 days later.
Radiomimetic Drug Studies
Cells (10 ~1) in early-to middle-log phase were diluted into 100 ~1 of YPD, spread on YPD-agar plates, and grown for an additional 16 hr at 30°C. Colonies were replica plated onto either YPD plates without radiomimetic drugs or YPD plates containing bleomycin (Sigma; resuspended at 10 mg/ml in H20)or streptonigrin (resuspended in dimethylformamide at 5 mg/ml). Plates were incubated at 30°C.
tell and mecl Mutant Strain Generation
The te/l and mecl mutant strains were generated using the direct gene deletion technique previously described (Baudin et al., 1993) . In brief, two oligonucleotides, each 60 nt in length, were generated; one oligonucleotide consists of 40 nt of sequence homologous to the 5' region of the deletion to be generated, followed by 20 nt of sequence homologous to the pRS series of yeast shuttle vectors (Sikorski and Hieter, 1989) . This sequence permits the amplification of any one of the yeast selectable markers cloned into the pRS vectors. The second oligonucleotide consists of 40 nt of sequence homologous to the 3' region of the deletion to be generated, followed by 20 nt of sequence from the opposing side of the selectable marker within the pRS vectors. The two oligonucleotides were used in a PCR to amplify the marker of choice from one of the pRS vectors (e.g., pRS3031HIS3). The PCR Weinert et al. (1994 ) Weinert et al. (1994 product thus consists of linear double-stranded DNA containing the yeast selectable marker and 40 bp of sequence homologous to the region flanking the deletion to be generated. This PCR product is transformed into yeast cells, and homologous recombination replaces the region to be deleted with the selectable marker. In our experience, 50%-80% of His + transformants in a his3A200 background are true deletions. The primers used for generating the tell and mecl deletion strains are listed in Table 3 . All PCRs were performed on a Perkin Elmer 9600 using the following cycling protocol: one cycle for 2 min at 94°C; 30 cycles of 1 rain at 94"C, 1 rain at 50°C, and 2 min at 72°C; followed by one cycle for 10 rain at 72°C. PCR amplification products were used directly in the transformations.
Cloning of TEL1
The TEL1 gene was cloned using a gap repair procedure (see Figure  2B) . First, the HIS3 gene and flanking sequence were amplified directly from YDM881 (telIAI::HIS31TEL1) cells using primers 1 and 4 listed in Table 3 . The PCR was done for one cycle at 94°C; 35 cycles of 1 min at 940C, 1 min at 45°C, and 2.5 min at 72°G; followed by one cycle for 10 min at 72°C. The 3.2 kb PCR product was gel purified, digested with EcoRI and Spel, and cloned into pRS316 (Sikorski and Hieter, 1989) . The resulting plasmid, pDM196, was linearized with EcoR47111, which cuts within the HIS3 gene, and transformed into YPH274. Ura + colonies were replica plated onto minimal plates lacking histidine. The resulting Ura + His-colonies were selected and grown up in minimal media, plasmid DNA was isolated, and restriction analysis was done to determine which plasmid had a successfully gaprepaired TEL1 gene.
